Nanjing Pharmaceutical and others establish a private equity investment fund company

Qichacha APP shows that recently, Nanjing Pharmaceutical Group Jiangfeng Equity Investment Fund Co., Ltd. was established. The legal representative is Peng Yuping, with a registered capital of 200 million yuan. Its business scope includes: equity investment; engaging in activities such as private equity fund investment, investment management, and asset management. Qichacha’s equity penetration reveals that the company is jointly held by Nanjing Pharmaceutical, Nanjing New Industrial Medical and Health Strong Chain Mergers and Acquisitions Equity Investment Partnership (Limited Partnership), among others. (People’s Financial News)

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments